Industry News
Pharmaceutical Industry News
What to Know About Covid Vaccines This Fall
The F.D.A. introduced new rules. Here’s what to know.
On the Health Matters podcast,…
On the Health Matters podcast, Gottlieb weighs in on affordability, policy shifts and the future of medical breakthroughs.
Artificial intelligence (AI) has…
Artificial intelligence (AI) has quickly moved beyond being a buzzword in healthcare marketing—it’s now powering real change. In the latest episode of The Next Marketing with HJ, Harshit Jain (HJ), Founder & Global CEO of
Amid uncertainty over how the…
Amid uncertainty over how the Trump administration would approach mRNA vaccines for the upcoming COVID-19 season, the FDA has approved updated shots from Pfizer and Moderna. But rather than granting the broad approvals the vaccines
The company’s three-prong…
The company's three-prong "Indivior Action Agenda" is all meant to boost U.S. growth of opioid use disorder treatment Sublocade.
A newly published report developed…
A newly published report developed by a group of partners, including Sanofi, shines a light on the far-reaching impacts of well-funded community health worker programs.
China biotech RemeGen and its new…
China biotech RemeGen and its new U.S. partner Vor Bio are on a roll with their first-in-class autoimmune treatment telitacicept. Two weeks after revealing the success of a phase 3 trial of telitacicept in Sjögren’s disease,
Eli Lilly’s Verzenio has proven…
Eli Lilly’s Verzenio has proven its ability to prolong the lives of patients with HR-positive, HER2-negative, node-positive high-risk early breast cancer, the company said Wednesday.
A new report from MassBio suggests…
A new report from MassBio suggests the state isn’t immune to the funding slowdowns and policy shifts that have put pressure on the industry over the past year and a half.
Phreesia is bringing Sesame Street…
Phreesia is bringing Sesame Street to the doctor’s office. The patient activation company has partnered with the nonprofit behind the TV show to work characters such as Elmo and Cookie Monster into joint campaigns aimed
For the third year in a row,…
For the third year in a row, Cleveland Diagnostics is commemorating September’s Prostate Cancer Awareness Month with its “A PSA on PSA” campaign that serves as a public service announcement about prostate-specific antigen testing.
Curious where audio in pharma is…
Curious where audio in pharma is headed? Discover the trends driving this season’s planning and innovation conversations.
The deal will bring together…
The deal will bring together Waltz's proprietary drug marketplaces and direct-to-payer model with Eversana's global pharmaceutical commercialization platform.
Akeso and Summit Therapeutics’…
Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown for the first time that it can extend patients’ lives. The result comes from a China-only phase 3 trial in certain patients with lung
Pfizer is laying off 100 employees…
Pfizer is laying off 100 employees in Bothell, Washington, which used to host Seagen’s global headquarters.
Weeks after telegraphing a series…
Weeks after telegraphing a series of upgrades to its Mexico operations over the next five years, Bayer is rolling up its sleeves with plans to overhaul a drug ingredient facility in Veracruz.
Nusano, a privately…
Nusano, a privately held physics company that specializes in making medical radioisotopes, cut the ribbon at a much-needed manufacturing plant in Utah.
On Monday, Argenx reported that…
On Monday, Argenx reported that its chief drug Vyvgart met the mark in a phase 3 trial assessing the FcRn blocker in the subset of generalized myasthenia gravis patients who are seronegative. Overall, seronegative patients
The company touts a large U.S….
The company touts a large U.S. market opportunity for scPharmaceuticals’ Furoscix, which recently expanded into chronic kidney disease.
Less than three weeks after…
Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq, the FDA has done an about-face, banning the use of the shot in the United States.